NON-MUCOSAL MELANOMA

Clinical trials for NON-MUCOSAL MELANOMA explained in plain language.

Never miss a new study

Get alerted when new NON-MUCOSAL MELANOMA trials appear

Sign up with your email to follow new studies for NON-MUCOSAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New Immune-Boosting combo enters fight against tough cancers

Disease control Ongoing

This study is testing whether a new immunotherapy drug (BGB-A445) works better when combined with an existing one (tislelizumab) to treat advanced bladder, kidney, or skin cancers. It aims to see if the combination can shrink tumors and is safe for patients. The trial is for peop…

Matched conditions: NON-MUCOSAL MELANOMA

Phase: PHASE1, PHASE2 • Sponsor: BeiGene • Aim: Disease control

Last updated Apr 02, 2026 14:57 UTC

NON-MUCOSAL MELANOMA

Get alerted when new NON-MUCOSAL MELANOMA trials appear

New Immune-Boosting combo enters fight against tough cancers